中天生物科技股份有限公司
該股 RSI(6) 為 30.8，處於中性區間，短線無明顯超買超賣訊號。股價跌破20日、60日、120日均線。短中期均線呈空頭排列，趨勢偏空。KD 指標中性（K=36.8）；MACD 柱狀體為負值，空方動能持續。 （自動產生 · 非投資建議）
中天生物科技股份有限公司為台灣領先的生技製藥公司。業務範疇涵蓋新藥開發、科學中藥及營養保健食品銷售。代表產品為化療輔助新藥，並透過子公司（如合一、泉盛）進行抗體藥物研究。此外經營生技創投與電子商務平台。公司成立於 2000 年，總部位於台灣台北市。
| 日期 | 外資 | 投信 | 自營商 | 合計 |
|---|---|---|---|---|
| 11-10 | -231 | 0 | +2 | -229 |
| 11-09 | +76 | 0 | +3 | +79 |
| 11-06 | +640 | 0 | -19 | +621 |
| 11-05 | +37 | 0 | +10 | +47 |
| 11-04 | -58 | 0 | -2 | -60 |
| 11-03 | +88 | 0 | -8 | +80 |
| 11-02 | +19 | 0 | 0 | +19 |
| 10-30 | -557 | 0 | +16 | -541 |
| 10-29 | -94 | 0 | 0 | -94 |
| 10-28 | -367 | 0 | +33 | -334 |
| 10-27 | -100 | 0 | -103 | -203 |
| 10-22 | -134 | 0 | +2 | -132 |
| 10-21 | +233 | 0 | +103 | +336 |
| 10-20 | -47 | 0 | 0 | -47 |
| 10-19 | -314 | 0 | 0 | -314 |
| 10-16 | +491 | 0 | +6 | +497 |
| 10-15 | +110 | 0 | -10 | +100 |
| 10-14 | +165 | 0 | +2 | +167 |
| 10-13 | +77 | 0 | +76 | +153 |
| 10-12 | +245 | 0 | +8 | +253 |
| 10-08 | +562 | 0 | +8 | +570 |
| 10-07 | +309 | 0 | 0 | +309 |
| 10-06 | -63 | 0 | -4 | -67 |
| 10-05 | -292 | 0 | +26 | -266 |
| 10-02 | +239 | 0 | -1 | +238 |
| 10-01 | -420 | 0 | +2 | -418 |
| 09-30 | +957 | 0 | +2 | +959 |
| 09-29 | +248 | 0 | -2 | +246 |
| 09-24 | -130 | 0 | +6 | -124 |
| 09-23 | +363 | 0 | 0 | +363 |
| 09-22 | +47 | 0 | +2 | +49 |
| 09-21 | -189 | 0 | -3 | -192 |
| 09-18 | +1,375 | 0 | 0 | +1,374 |
| 09-17 | +240 | 0 | +4 | +244 |
| 09-16 | +31 | 0 | -2 | +29 |
| 09-15 | -21 | 0 | +20 | -2 |
| 09-14 | +119 | 0 | +5 | +124 |
| 09-11 | -125 | 0 | 0 | -125 |
| 09-10 | +78 | 0 | +1 | +79 |
| 09-09 | -119 | 0 | -44 | -163 |
| 09-08 | +298 | 0 | +6 | +305 |
| 09-07 | +83 | 0 | +16 | +99 |
| 09-04 | -201 | 0 | +7 | -194 |
| 09-03 | -302 | 0 | +33 | -269 |
| 09-02 | +154 | 0 | 0 | +154 |
| 09-01 | -104 | 0 | 0 | -104 |
| 08-31 | -179 | 0 | +4 | -175 |
| 08-28 | +243 | 0 | -4 | +239 |
| 08-27 | -60 | 0 | -12 | -73 |
| 08-26 | +355 | 0 | +4 | +359 |
| 08-25 | -224 | 0 | -14 | -238 |
| 08-24 | -609 | 0 | -10 | -618 |
| 08-21 | +219 | 0 | -4 | +215 |
| 08-20 | +424 | 0 | +14 | +439 |
| 08-19 | -66 | 0 | +4 | -62 |
| 08-18 | +71 | 0 | +2 | +72 |
| 08-17 | -127 | 0 | +2 | -124 |
| 08-14 | -332 | 0 | +2 | -330 |
| 08-13 | +424 | 0 | 0 | +424 |
| 08-12 | -217 | 0 | -10 | -227 |
| 08-11 | +203 | 0 | +6 | +209 |
| 08-10 | -43 | 0 | -24 | -67 |
| 08-07 | +184 | 0 | -5 | +178 |
| 08-06 | -141 | 0 | -10 | -151 |
| 08-05 | +33 | 0 | +4 | +36 |
| 08-04 | +51 | 0 | -6 | +45 |
| 08-03 | -1,117 | 0 | +4 | -1,113 |
| 07-31 | -614 | 0 | -5 | -620 |
| 07-30 | -78 | 0 | -10 | -88 |
| 07-29 | -153 | 0 | +6 | -147 |
| 07-28 | +101 | 0 | -1 | +100 |
| 07-27 | +1 | 0 | -2 | -2 |
| 07-24 | -283 | 0 | +2 | -281 |
| 07-23 | +37 | 0 | -4 | +33 |
| 07-22 | -404 | 0 | -2 | -406 |
| 07-21 | -106 | 0 | -2 | -108 |
| 07-20 | +305 | 0 | -4 | +301 |
| 07-17 | -357 | 0 | -14 | -371 |
| 07-16 | -77 | 0 | +10 | -68 |
| 07-15 | -295 | 0 | +36 | -259 |
| 07-14 | +30 | 0 | -20 | +10 |
| 07-13 | -469 | 0 | +9 | -460 |
| 07-09 | -1,337 | 0 | -10 | -1,347 |
| 07-08 | -3,030 | 0 | -24 | -3,054 |
| 07-07 | -594 | 0 | -1 | -595 |
| 07-06 | -762 | 0 | -43 | -805 |
| 07-03 | +2,357 | 0 | +61 | +2,418 |
| 07-02 | -662 | 0 | +2 | -660 |
| 07-01 | +155 | 0 | -24 | +131 |
| 06-30 | +138 | 0 | -28 | +110 |
| 06-29 | +812 | 0 | +2 | +814 |
| 06-26 | -1,852 | 0 | 0 | -1,852 |
| 06-25 | +159 | 0 | +11 | +170 |
| 06-24 | +269 | 0 | -2 | +267 |
| 06-23 | +896 | 0 | +18 | +914 |
| 06-22 | -65 | 0 | 0 | -65 |
| 06-18 | +273 | 0 | +9 | +282 |
| 06-17 | -256 | 0 | -26 | -282 |
| 06-16 | -173 | 0 | 0 | -173 |
| 06-15 | -106 | 0 | +4 | -102 |
| 06-12 | +164 | 0 | +18 | +182 |
| 06-11 | +96 | 0 | -8 | +88 |
| 06-10 | +294 | 0 | -4 | +290 |
| 06-09 | -267 | 0 | +2 | -265 |
| 06-08 | +273 | 0 | -8 | +265 |
| 06-05 | -23 | 0 | -8 | -31 |
| 06-04 | +10 | 0 | +12 | +22 |
| 06-03 | +177 | 0 | 0 | +177 |
| 06-02 | +297 | 0 | -14 | +283 |
| 06-01 | +602 | 0 | +14 | +616 |
| 05-29 | -233 | 0 | +8 | -225 |
| 月份 | 營收 | MoM% | YoY% |
|---|---|---|---|
| 2026/10 | 1.70 億 | +12.7% | -3.1% |
| 2026/09 | 1.50 億 | -2.6% | -6.5% |
| 2026/08 | 1.54 億 | +1.6% | -1.3% |
| 2026/07 | 1.52 億 | -5.6% | -2.8% |
| 2026/06 | 1.61 億 | +1.8% | +11.8% |
| 2026/05 | 1.58 億 | -1.0% | +4.1% |
| 2026/04 | 1.60 億 | -5.8% | +1.8% |
| 2026/03 | 1.70 億 | +11.6% | +7.7% |
| 2026/02 | 1.52 億 | -15.6% | +14.0% |
| 2026/01 | 1.80 億 | +9.5% | +8.7% |
| 2025/12 | 1.64 億 | -4.0% | +5.9% |
| 2025/11 | 1.71 億 | - | +8.1% |